# 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

> **NCT07325240** · PHASE4 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 30 (estimated)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution
- **DRUG:** Latanoprost 0.005% Ophthalmic Solution

## Key facts

- **NCT ID:** NCT07325240
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-21
- **Primary completion:** 2027-07
- **Final completion:** 2027-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07325240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07325240, "24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07325240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*